In a major move that’s set to shake up the pharmaceutical industry, Granules India has announced the acquisition of Senn Chemicals AG, a Swiss-based leader in peptide manufacturing. This strategic acquisition marks Granules India’s entry into the Contract Development and Manufacturing Organization (CDMO) business, a fast-growing sector in the global pharmaceutical landscape. Here’s why this…
